Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2008 2
2010 4
2011 1
2012 5
2013 3
2014 2
2015 6
2016 2
2017 5
2018 4
2019 13
2020 7
2021 20
2022 18
2023 18
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Designing biological compartmentalization.
Chen AH, Silver PA. Chen AH, et al. Trends Cell Biol. 2012 Dec;22(12):662-70. doi: 10.1016/j.tcb.2012.07.002. Epub 2012 Jul 27. Trends Cell Biol. 2012. PMID: 22841504 Review.
MTORC1-Regulated Metabolism Controlled by TSC2 Limits Cardiac Reperfusion Injury.
Oeing CU, Jun S, Mishra S, Dunkerly-Eyring BL, Chen A, Grajeda MI, Tahir UA, Gerszten RE, Paolocci N, Ranek MJ, Kass DA. Oeing CU, et al. Among authors: chen a. Circ Res. 2021 Mar 5;128(5):639-651. doi: 10.1161/CIRCRESAHA.120.317710. Epub 2021 Jan 6. Circ Res. 2021. PMID: 33401933 Free PMC article.
Narcolepsy Treatment: Voices of Adolescents.
Xiao L, Chen A, Parmar A, Frankel L, Toulany A, Murray BJ, Narang I. Xiao L, et al. Among authors: chen a. Behav Sleep Med. 2022 Mar-Apr;20(2):260-268. doi: 10.1080/15402002.2021.1916496. Epub 2021 Apr 20. Behav Sleep Med. 2022. PMID: 33877929
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Brown ER, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; COVID-19 Phase 3 Prevention Trial Team. O'Brien MP, et al. JAMA. 2022 Feb 1;327(5):432-441. doi: 10.1001/jama.2021.24939. JAMA. 2022. PMID: 35029629 Free PMC article. Clinical Trial.
Glucagon-receptor-antagonism-mediated β-cell regeneration as an effective anti-diabetic therapy.
Xi Y, Song B, Ngan I, Solloway MJ, Humphrey M, Wang Y, Mondal K, Wu H, Liu W, Lindhout DA, Li D, Matern H, Kekatpure A, Haldankar R, Kaplan DD, Yang H, Pedersen O, Chen A, Zhou M, Winans B, Guo W, Kutach A, Fanget M, Fox M, Tang J, Zha J, Younis H, Shen D, DePaoli A, Tian H, Liu Z. Xi Y, et al. Among authors: chen a. Cell Rep. 2022 May 31;39(9):110872. doi: 10.1016/j.celrep.2022.110872. Cell Rep. 2022. PMID: 35649369 Free article.
111 results